CHARLES SCHWAB INVESTMENT MANAGEMENT INC - OMEGA THERAPEUTICS INC ownership

OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 53 filers reported holding OMEGA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of OMEGA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$139,989
-61.6%
65,1110.0%0.00%
Q2 2023$364,622
+10.5%
65,111
+23.3%
0.00%
Q1 2022$330,000
+48.6%
52,799
+169.8%
0.00%
Q4 2021$222,000
-39.8%
19,5720.0%0.00%
Q3 2021$369,00019,5720.00%
Other shareholders
OMEGA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 352,941$758,8235.08%
Flagship Pioneering Inc. 29,225,579$62,834,9964.56%
HARBOURVEST PARTNERS LLC 3,512,110$7,551,0372.56%
CHI Advisors LLC 1,055,882$2,270,1460.90%
Knoll Capital Management, LLC 173,010$371,9710.39%
Artal Group S.A. 2,533,045$5,4460.23%
683 Capital Management, LLC 508,242$1,092,7200.08%
PLATINUM INVESTMENT MANAGEMENT LTD 887,017$1,907,0870.07%
ORACLE INVESTMENT MANAGEMENT INC 50,000$107,5000.03%
STATE OF WISCONSIN INVESTMENT BOARD 1,857,265$3,993,1200.01%
View complete list of OMEGA THERAPEUTICS INC shareholders